Patrick J. Heron - 20 Jul 2021 Form 4 Insider Report for Imago BioSciences, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 20 Jul 2021
Net transaction value: +$3,000,000
SEC form: 4
Accepted by SEC: 20 Jul 2021, 17:54:29 UTC
Prior SEC filing: 15 Jul 2021
Next SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Patrick J. Heron

Key filing fact

Patrick J. Heron filed Form 4 for Imago BioSciences, Inc. on 20 Jul 2021.

Key facts

This page summarizes Patrick J. Heron's Form 4 filing for Imago BioSciences, Inc..
14 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 20 Jul 2021, 17:54.

Change

Previous filing in this sequence was filed on 15 Jul 2021.
Current net transaction value: +$3,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMGO transaction

Common Stock

Purchase

Transaction value: $665,312
Shares: +41,582
Change %
Price: $16.00
Shares after: 41,582
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F1

IMGO transaction

Common Stock

Purchase

Transaction value: $2,334,688
Shares: +145,918
Change %
Price: $16.00
Shares after: 145,918
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F2

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +341,932
Change %: +822%
Price
Shares after: 383,514
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F1, F3

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +211,069
Change %: +55%
Price
Shares after: 594,583
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F1, F3

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +64,360
Change %: +11%
Price
Shares after: 658,943
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F1, F3

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,199,890
Change %: +822%
Price
Shares after: 1,345,808
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F2, F3

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +740,673
Change %: +55%
Price
Shares after: 2,086,481
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F2, F3

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +225,850
Change %: +11%
Price
Shares after: 2,312,331
Date: 20 Jul 2021
Ownership: See Footnote
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMGO transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -341,932
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 341,932
Exercise price
Footnotes: F1, F3

IMGO transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -211,069
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 211,069
Exercise price
Footnotes: F1, F3

IMGO transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -64,360
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 64,360
Exercise price
Footnotes: F1, F3

IMGO transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -1,199,890
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 1,199,890
Exercise price
Footnotes: F2, F3

IMGO transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -740,673
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 740,673
Exercise price
Footnotes: F2, F3

IMGO transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -225,850
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 225,850
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares are held directly by Frazier Healthcare VII-A, L.P. ("FH VIIA"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any.

Footnote F2

These shares are held directly by Frazier Healthcare VII, L.P. ("FH VII"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any.

Footnote F3

Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .